NASDAQ
PRPO

Precipio Inc

Diagnostics & Research
Healthcare

Prices are adjusted according to historical splits.

Precipio Inc Stock Price

Vitals

Today's Low:
$0.284
Today's High:
$0.31
Open Price:
$0.284
52W Low:
$0.28
52W High:
$1.26
Prev. Close:
$0.284
Volume:
97371

Company Statistics

Market Cap.:
$7.83 million
Book Value:
0.509
Revenue TTM:
$10.96 million
Operating Margin TTM:
-99.24%
Gross Profit TTM:
$2.39 million
Profit Margin:
-98.5%
Return on Assets TTM:
-29.9%
Return on Equity TTM:
-62.21%

Company Profile

Precipio Inc had its IPO on 2000-07-18 under the ticker symbol PRPO.

The company operates in the Healthcare sector and Diagnostics & Research industry. Precipio Inc has a staff strength of 53 employees.

Stock update

Shares of Precipio Inc opened at $0.28 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $0.28 - $0.31, and closed at $0.3.

This is a +3.87% increase from the previous day's closing price.

A total volume of 97,371 shares were traded at the close of the day’s session.

In the last one week, shares of Precipio Inc have slipped by -11.41%.

Precipio Inc's Key Ratios

Precipio Inc has a market cap of $7.83 million, indicating a price to book ratio of 0.8422 and a price to sales ratio of 1.4963.

In the last 12-months Precipio Inc’s revenue was $10.96 million with a gross profit of $2.39 million and an EBITDA of $-9547000. The EBITDA ratio measures Precipio Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Precipio Inc’s operating margin was -99.24% while its return on assets stood at -29.9% with a return of equity of -62.21%.

In Q2, Precipio Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 49.8%.

Precipio Inc’s PE and PEG Ratio

Forward PE
0
Trailing PE
0
PEG
0

Its diluted EPS in the last 12-months stands at $-0.46 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Precipio Inc’s profitability.

Precipio Inc stock is trading at a EV to sales ratio of 1.2441 and a EV to EBITDA ratio of -1.1167. Its price to sales ratio in the trailing 12-months stood at 1.4963.

Precipio Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$19.47 million
Total Liabilities
$4.72 million
Operating Cash Flow
$0
Capital Expenditure
$32000
Dividend Payout Ratio
0%

Precipio Inc ended 2024 with $19.47 million in total assets and $0 in total liabilities. Its intangible assets were valued at $19.47 million while shareholder equity stood at $14.03 million.

Precipio Inc ended 2024 with $0 in deferred long-term liabilities, $4.72 million in other current liabilities, 275000.00 in common stock, $-97620000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $2.57 million and cash and short-term investments were $2.57 million. The company’s total short-term debt was $407,000 while long-term debt stood at $120000.00.

Precipio Inc’s total current assets stands at $4.35 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $884000.00 compared to accounts payable of $2.40 million and inventory worth $537000.00.

In 2024, Precipio Inc's operating cash flow was $0 while its capital expenditure stood at $32000.

Comparatively, Precipio Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price
$0.3
52-Week High
$1.26
52-Week Low
$0.28
Analyst Target Price
$2

Precipio Inc stock is currently trading at $0.3 per share. It touched a 52-week high of $1.26 and a 52-week low of $1.26. Analysts tracking the stock have a 12-month average target price of $2.

Its 50-day moving average was $0.35 and 200-day moving average was $0.58 The short ratio stood at 2.42 indicating a short percent outstanding of 0%.

Around 290.7% of the company’s stock are held by insiders while 812.5% are held by institutions.

Frequently Asked Questions About Precipio Inc

The stock symbol (also called stock or share ticker) of Precipio Inc is PRPO

The IPO of Precipio Inc took place on 2000-07-18

Similar Industry Stocks (Diagnostics & Research)

Last Price
Chg
Chg%
$1.3
0
+0.05%
$22.01
-0.74
-3.25%
$80
-2
-2.44%
$23.18
-1.22
-5%
$72.82
-1.05
-1.42%
$37.02
-0.13
-0.35%
$19.13
-0.98
-4.87%
$147.7
-5.6
-3.65%
$2.03
0.06
+3.05%
$0.59
0
+0.02%

Most Active

Last Price
Chg
Chg%
Amyris Inc (AMRS)
$0.14
0.07
+100%
$0.12
0.04
+45.29%
$0.96
0.05
+5.4%
$1.34
-0.35
-20.71%
Humbl Inc (HMBL)
$0
0
0%

Top Gainers

Last Price
Chg
Chg%
$0
0
+172200%
$0
0
+51200%
$283
280.03
+9428.62%
$11.2
10.57
+1667.68%
Latch Inc (LTCHW)
$0.01
-0.03
+1550%

Top Losers

Last Price
Chg
Chg%
$0.19
-123.15
-99.85%
$0
-0.11
-99.55%
$0
-0
-97.96%
$0
-0.01
-93.94%
$0.01
-0.06
-92.24%

About

Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; HemeScreen, a suite of robust genetic diagnostic panels; and COVID-19 antibody tests. It sells ICE- technology kits to bio-pharma customers. The company is based in New Haven, Connecticut.

Address

4 Science Park, New Haven, CT, United States, 06511